Real-world outcomes using PD-1 antibodies and BRAF plus MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and SwitzerlandJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGYIF82022-12-1216OA
Biomarkers of Tretinoin Precursors and Tretinoin Efficacy in Patients With Moderate to Severe Facial Photodamage A Randomized Clinical TrialJAMA DERMATOLOGYIF112022-08-018OA
The skin microbiota as a link between rosacea and its systemic comorbiditiesINTERNATIONAL JOURNAL OF DERMATOLOGYIF3.22020-02-1110PREAI
Characterization and Analysis of the Skin Microbiota in Rosacea: A Case-Control StudyAMERICAN JOURNAL OF CLINICAL DERMATOLOGYIF8.82019-09-0949OAAI
Impact of lifestyle and demographics on the gut microbiota of acne patients and the response to minocyclineJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72019-09-010OAAI
The role of photo-induced collagen degeneration in the development of telangiectasias in rosaceaJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72019-09-010OAAI
Finegoldia magna and Corynebacterium kroppenstedtii are significantly enriched in rosacea independent of rosacea subtype: Results of a case-control studyJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72017-10-011OAAI
Characterization of the skin microbiota in rosaceaJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72017-05-010OAAI
Pigmentation in African American skin decreases with skin agingJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82016-10-0115PREAI
The association of gastrointestinal disorders and worry with rosacea supports the concept of a gut-brain-skin interaction in rosaceaJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72016-05-010OAAI
Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: Results of a case-control studyJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82015-10-01110PREAI
Improving acne keloidalis nuchae with targeted ultraviolet B treatment: a prospective, randomized, split-scalp comparison studyBRITISH JOURNAL OF DERMATOLOGYIF9.62014-10-0113OAAI